E2F1 and prostate cancer: Consistent with our observation, LSD1 co-occupied with E2F1, demethylated H3K9me2, and promoted the LSD1-E2F1 co-target genes expression, but has no effects on H3K4me2, thereby promoting S-phase entry and tumorigenesis in prostate cancer cells56.